CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction Dapagliflozin for treating chronic heart failure with reduced ejection fraction Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure Ejection Fraction Pros and Cons: JACC State-of-the-Art Review The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus

Editorial2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL:Can J Cardiol. Article Link

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett. Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF